Stock comparison
Iovance Biotherapeutics
IOVA$1.75BHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$69.12BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
IOVA 07 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
IOVA0wins
7winsJSLL.BO
24F
B84
41F
A87
39F
A92
3F
C66
2F
B75
28F
A91
33F
A95
Side-by-side metrics
| Metric | IOVA | JSLL.BO |
|---|---|---|
| Market cap | $1.75B | $69.12B Winner |
| P/E (TTM) | Winner: - | 33.2x |
| EV/EBIT | Winner: - | 24.1x |
| ROIC (TTM) | -45.33% | 39.15% Winner |
| Gross margin | Winner: 114.51% | 88.58% |
| Net margin | -123.9% | 27.68% Winner |
| Revenue CAGR 5y | - | 57.81% |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | Winner: 0.1x | 0.3x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IOVA leads on
- P/E (TTM)-vs 33.2x+112%
- EV/EBIT-vs 24.1x+111%
- Debt / Equity0.1xvs 0.3x+76%
- Gross margin114.51%vs 88.58%+23%
JSLL.BO leads on
- ROIC (TTM)39.15%vs -45.33%+186%
- Net margin27.68%vs -123.9%+122%
- Market cap$69.12Bvs $1.75B+97%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.